Zoetis

$158.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$3.13 (+2.02%) As of 5:16 PM UTC today

Why Robinhood?

You can buy or sell Zoetis and other stocks, options, and ETFs commission-free!

About ZTS

Zoetis, Inc. discovers, develops, and manufactures a portfolio of animal health medicines and vaccines. The firm operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices, and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ. The listed name for ZTS is ZOETIS INC.

CEO

Kristin C. Peck

Employees

11,300

Headquarters

Parsippany, New Jersey

Founded

1952

Market Cap

76.74B

Price-Earnings Ratio

45.36

Dividend Yield

0.55

Average Volume

2.58M

High Today

$158.72

Low Today

$155.93

Open Price

$156.34

Volume

469.13K

52 Week High

$176.64

52 Week Low

$90.14

ZTS News

BenzingaFeb 28

The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among

Analyst Ratings

63%

of 19 ratings

Buy

63%

Hold

32%

Sell

ZTS Earnings

$0.64

$0.79

$0.95

$1.10

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

$0.87 per share

Actual

$0.91 per share

Replay Earnings Call